Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bioline hydroxyzine pamoate recall

Executive Summary

Totaling about 237 bottles of the antihistamine product in 50 mg caps announced by FDA Oct. 1. Bioline says the bottles in two lots (91009 and 91240) may contain 0.2 mg tablets of the antihypertensive drug clonidine HCl. The agency advises patients taking a drug labeled as the Bioline antihistamine to be sure it contains capsules and not peach-colored, scored tablets with a "dp" logo above the scoreline and "02" below. Both drugs were made and labeled by Duramed using Bioline labels.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS018161

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel